Charles Schwab’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
83,465
+4,840
+6% +$53.5K ﹤0.01% 2994
2026
Q1
$730K Sell
78,625
-7,257
-8% -$70.3K ﹤0.01% 2996
2025
Q4
$867K Buy
85,882
+261
+0.3% +$2.6K ﹤0.01% 2977
2025
Q3
$920K Sell
85,621
-3,237
-4% -$36.1K ﹤0.01% 2980
2025
Q2
$1.21M Buy
88,858
+75,767
+579% +$1.06M ﹤0.01% 2838
2025
Q1
$167K Buy
13,091
+114
+0.9% +$1.62K ﹤0.01% 3278
2024
Q4
$156K Buy
+12,977
New +$137K ﹤0.01% 3354

Other funds holding DCTH

Charles Schwab's DCTH Position: Q2 2026 in Review

Charles Schwab increased its Delcath Systems (DCTH) stake by 6.2% in Q2 2026, buying an estimated $53.5K and bringing the position to 83,465 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

Charles Schwab first reported a position in DCTH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.21M in Q2 2025. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

  • Charles Schwab held 83,465 shares of Delcath Systems worth $1.05M as of Q2 2026.
  • Charles Schwab bought 4,840 Delcath Systems shares in Q2 2026, an estimated $53.5K.
  • Delcath Systems made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2994 holding.
  • Charles Schwab first reported a position in Delcath Systems in Q4 2024 and has held it in 7 quarters since.
  • Charles Schwab's Delcath Systems position peaked at $1.21M in Q2 2025.
  • 120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.